PremiumOTLK

Ocular Therapeutix: Analyst raises price target to $10 per share

An analyst raised the stock's price target to $10, almost ten times the current price.

By the SpyStocks desk · 2mo ago · 1 min read

Related Stories

Three analysts and AI industry experts re-rate Nvidia - we've compiled everything important for you to know

AnalystsNVDA1d ago5 min read

KURA: buy recommendation from analysts

PremiumAnalystsKURA1w ago1 min read

Onds: Oppenheimer raises price target

PremiumAnalystsONDS1w ago1 min read